- ►vitality.net [PDF] MC Sokol, KA McGuigan, RR Verbrugge, RS … - Medical Care, 2005 - journals.lww.com This research was designed and conducted by the authors as part of their
employment with Medco Health Solutions, Inc. The manuscript was reviewed through
an internal publications review process to ensure data integrity and ... Cited by 253 - Related articles - BL Direct - All 12 versions
- ►nih.gov SH Simpson, DT Eurich, SR Majumdar, RS … - bmj, 2006 - bmjcom.highwire.org You are seeing this message because your web browser does not support basic web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Objective To evaluate the ... Cited by 200 - Related articles - BL Direct - All 12 versions
PM Ho, JS Rumsfeld, FA Masoudi, DL McClure … - Archives of Internal Medicine, 2006 - Am Med Assoc Results Nonadherent patients (proportion of days covered, <80%; prevalence,
21.3%) were younger and had fewer comorbidities compared with adherent patients.
During follow-up, nonadherent patients had higher glycosylated hemoglobin, ... Cited by 119 - Related articles - BL Direct - All 4 versions
M Pladevall, L Williams, LA Potts, G Divine, H … - Diabetes Care, 2004 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—The study setting was a large, integrated delivery
and financial system serving the residents of southeastern Michigan. The study
population consisted of 677 randomly selected patients aged ≥18 years ... Cited by 93 - Related articles - BL Direct - All 7 versions
SE Andrade, KH Kahler, F Frech, KA Chan - Pharmacoepidemiology and drug safety, 2006 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 87 - Related articles - BL Direct - All 4 versions
RR Rubin - The American journal of medicine, 2005 - Elsevier Many patients who have type 2 diabetes mellitus (DM) require several different
medications. Although these agents can substantially reduce diabetes-related
morbidity and mortality, the extent of treatment benefits may be limited by ... Cited by 82 - Related articles - All 7 versions
SV Kane - Alimentary Pharmacology and Therapeutics, 2006 - medscape.com Formulations to deliver 5-aminosalicylic acid to the disease activity site, both
orally and topically, are often inconvenient and require multiple daily dosing.
Such regimens can interfere with normal life and reduce the overall quality ... Cited by 76 - Related articles - BL Direct - All 9 versions
- ►atsjournals.org JA Krishnan, KA Riekert, JV McCoy, DY … - American journal of respiratory and critical care …, 2004 - Am Thoracic Soc Despite the efficacy of corticosteroid therapy, patients hospitalized for asthma
exacerbations are at high risk for re-exacerbation and death after discharge.
The objective of this prospective cohort study was to evaluate adherence to ... Cited by 68 - Related articles - All 14 versions
MK Rhee, W Slocum, DC Ziemer, SD Culler, CB … - The Diabetes Educator, 2005 - tde.sagepub.com From the Division of Endocrinology and Metabolism, Department of Medicine, Emory
University School of Medicine, Atlanta, Georgia (Drs Rhee, Ziemer, Cook,
El-Kebbi, Gallina, Barnes, Phillips); the Strategic National Stockpile ... Cited by 64 - Related articles - All 3 versions
M Korytkowski, L Niskanen, T Asakura - Clinical therapeutics, 2005 - Elsevier Data from clinical studies publishedthrough June 2005 that evaluated the safety
or efficacy of FlexPen in patients with type 1 or type 2 diabetes were reviewed.
Key studies were selected following assessment of the sponsor's reference ... Cited by 52 - Related articles - All 3 versions
